ERBB2 and breast neoplasm: After 25-33 weeks, tumor incidence in the DMBA plus MPA group reached 50%. All DMBA plus MPA-induced tumors were positive for PR and ERα but negative for HER2. The PTEN/ PIK3CA, but not TP53 and GATA3, genes were frequently mutated in the breast tumors.